Novartis Ag (NVS) Exchange Rate Effect (2009 - 2026)

Novartis Ag has disclosed Exchange Rate Effect across 18 years of filings, most recently posting -$18.0 million for Q2 2026.

• In Q2 2026, Exchange Rate Effect fell 104.71% year-over-year to -$18.0 million; the TTM figure through Jun 2026 stood at -$81.0 million (down 119.1% YoY), while the FY2025 annual figure was $576.0 million, up 293.29% from the prior year.
• Exchange Rate Effect came in at -$18.0 million for Q2 2026 at Novartis Ag, up from -$77.0 million in the prior quarter.
• In the past five years, Exchange Rate Effect ranged from a high of $382.0 million in Q2 2025 to a low of -$314.0 million in Q4 2024.
• Average Exchange Rate Effect over 5 years is $13.9 million, with a median of -$20.0 million recorded in 2025.
• Year-over-year, Exchange Rate Effect tumbled 3300.0% in 2024 and jumped 1223.53% in 2025.
• Over 5 years, Exchange Rate Effect stood at $141.0 million in 2022, then grew by 13.48% to $160.0 million in 2023, then plunged by 296.25% to -$314.0 million in 2024, then surged by 111.46% to $36.0 million in 2025, then plunged by 150.0% to -$18.0 million in 2026.
• Per Business Quant data, the three most recent Exchange Rate Effect figures were -$18.0 million in Q2 2026, -$77.0 million in Q1 2026, and $36.0 million in Q4 2025.